Advent Bio-Services in Cambridge have just confirmed that they’ve made 4 vaccine doses for Joel. This personalised cancer vaccine is made from Joel’s own brain tumour lysate taken from frozen tissue, following his surgery. These have been combined with his white blood cells which were recently extracted at Kings College Hospital, to cultivate antibodies. This is such an incredible milestone. It means that Joel can now finally commence the treatment for which we’ve been fundraising since August 2020. None of this would have been possible without the extraordinarily generous and utterly incredible amount of donations that family, friends and strangers have made toward the fund, for which we are forever grateful. We will never be able to thank everyone enough for the amazing opportunity they’ve given Joel.
Obviously, this is just the beginning of a new stage for Joel. The treatment is not a cure, but research shows that it prolongs life, during which we can explore other emerging medical trials and treatments. To that end we still need to be raising funds both to continue his existing treatment and to maximise the opportunities that arise in the future. If Joel can continue to live longer then he stands a chance of making the most of life.
Market Data 
Markets 
AI
